Streamlining Devices Used by Seniors to Improve Quality of Life with Gary Rotman and Bruce Barnet SiMPL Technology TRANSCRIPT
Download PDFOct 20, 2021
Gary Rotman and Bruce Barnet are Co-Founders of SiMPL Technology, a company designing and selling simple tech products for seniors and their caregivers. With a particular focus on people with cognitive challenges and discomfort with digital technology, SiMPL is bringing solutions to the market that solve such challenges...
Oct 20, 2021
Gary Rotman and Bruce Barnet are Co-Founders of SiMPL Technology, a company designing and selling simple tech products for seniors and their caregivers. With a particular focus on people with cognitive challenges and discomfort with digital technology, SiMPL is bringing solutions to the market that solve such challenges...
Precision Intracoronary Imaging Software Powers Understanding of Optical Coherence Tomography with Dr. Nick West Abbott TRANSCRIPT
Download PDFOct 18, 2021
Dr. Nick West is the Chief Medical Officer and DVP Global Medical Affairs for Vascular at Abbott. With the launch of the Ultreon software 1.0, Abbott is bringing a new level of analysis to their Optical Coherence Tomography intracoronary imaging tool.
Nick explains, "And the idea of this software package is, on top of...
Oct 18, 2021
Dr. Nick West is the Chief Medical Officer and DVP Global Medical Affairs for Vascular at Abbott. With the launch of the Ultreon software 1.0, Abbott is bringing a new level of analysis to their Optical Coherence Tomography intracoronary imaging tool.
Nick explains, "And the idea of this software package is, on top of...
Developing Inhibitor Drugs for Use with Antibiotics to Combat Antimicrobial Drug Resistance with Dr. Mike Dudley Qpex Biopharma TRANSCRIPT
Download PDFOct 13, 2021
Dr. Mike Dudley is President and CEO of QpexBiopharma and seeing drug-resistant infections occurring inside the hospital as well as outside the hospital. Qpex is developing IV and oral drugs that are designed to overcome resistance mechanisms in bacteria that render penicillin-like drugs inactive.
Mike explains, "We...